Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
According to a survey conducted by FOGSI last year, 92% of the doctors opined that anaemia due to iron deficiency can be eradicated in five years
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Subscribe To Our Newsletter & Stay Updated
